The 12th General Assembly of Asia Pacific Organisation for Cancer Prevention
Nirmala Bhoo Pathy shared a post by Abhishek Shankar, Associate Professor, Department of Radiation Oncology at on LinkedIn, adding:
“Come join us in the 12th General Assembly of Asia Pacific Organisation for Cancer Prevention (APOCP) taking place from September 19-21, 2024, in the stunning city of Bishkek, Kyrgyzstan.”
Quoting Abhishek Shankar’s post:
We are thrilled to invite you to the upcoming 12th General Assembly of APOCP, taking place from September 19-21, 2024, in the stunning city of Bishkek, Kyrgyzstan. This prestigious event will bring together a diverse group of global leaders, researchers, healthcare professionals, and policymakers who are dedicated to advancing cancer prevention across the Asia-Pacific region.
As the Asia-Pacific region continues to face significant challenges in cancer control, this assembly will serve as a vital platform for collaboration, innovation, and knowledge exchange. Attendees will have the opportunity to engage in in-depth discussions on the latest research, strategies, and technologies in cancer prevention. The event will feature keynote speeches from world-renowned experts, interactive panel discussions, and a showcase of cutting-edge research and successful case studies from across the region.
The 12th General Assembly is not just a conference but a call to action. By attending, you will be contributing to the collective effort to reduce cancer incidence and mortality through effective prevention strategies tailored to the unique needs of our region. This is your chance to network with like-minded professionals, form valuable partnerships, and be part of a movement that is making a real difference in global health.
Don’t miss this unparalleled opportunity to shape the future of cancer prevention in the Asia-Pacific. Register now and join us in Bishkek for what promises to be an inspiring and impactful event!
Source: Nirmala Bhoo Pathy/LinkedIn and Abhishek Shankar/LinkedIn
Nirmala Bhoo-Pathy is as a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician in Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy.
Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.